| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 13001 | 10 | 12997 2003 BIOCHEMICAL PHARMACOLOGY 65(11):1889-1896
Zhang WS; Purchio A; Chen K; Burns SM; Contag CH; Contag PR
In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors | 0 | 0
|
| 13002 | 24 | 12998 2003 BIOCHEMISTRY 42(5):1245-1253
Guengerich FP; Hanna IH; Martin MV; Gillam EMJ
Role of glutamic acid 216 in cytochrome P450 2D6 substrate binding and catalysis | 0 | 0
|
| 13003 | 5 | 12999 2003 BIOCHEMISTRY 42(21):6363-6369
Marques-Soares C; Dijols S; Macherey AC; Wester MR; Johnson EF; Dansette PM; Mansuy D
Sulfaphenazole derivatives as tools for comparing cytochrome P4502C5 and human cytochromes P4502Cs: Identification of a new high affinity substrate common to those enzymes | 1 | 0
|
| 13004 | 7 | 13001 2003 BIOCHEMISTRY 42(23):7068-7076
Worrall JAR; Reinle W; Bernhardt R; Ubbink M
Transient protein interactions studied by NMR spectroscopy: The case of cytochrome C and adrenodoxin | 0 | 0
|
| 13005 | 20 | 13002 2003 BIOCHEMISTRY-MOSCOW 68(1):86-98
Gilep AA; Estabrook RW; Usanov SA
Molecular cloning and heterologous expression in E-coli of cytochrome P45017 alpha comparison of structural and functional properties of substrate-specific cytochromes P450 from different species | 0 | 0
|
| 13006 | 4 | 13003 2003 BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 1609(1):1-18
Hagenbuch B; Meier PJ
The superfamily of organic anion transporting polypeptides | 3 | 0
|
| 13007 | 11 | 13004 2003 BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION 1625(3):229-238
Seralini GE; Tomilin A; Auvray P; Nativelle-Serpentini C; Sourdaine P; Moslemi S
Molecular characterization and expression of equine testicular cytochrome P450 aromatase | 0 | 0
|
| 13008 | 6 | 13005 2003 BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION 1627(2-3):121-128
Mizuno D; Takahashi Y; Hiroi T; Imaoka S; Kamataki T; Funae Y
A novel transcriptional element which regulates expression of the CYP2D4 gene by Oct-1 and YY-1 binding | 0 | 0
|
| 13009 | 28 | 13006 2003 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1619(3):223-234
Akiyama TE; Gonzalez FJ
Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors | 0 | 0
|
| 13010 | 6 | 13007 2003 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1619(3):254-262
Rivera-Rivera I; Kim J; Kemper B
Transcriptional analysis in vivo of the hepatic genes, Cyp2b9 and Cyp2b10, by intravenous administration of plasmid DNA in mice | 0 | 0
|
| 13011 | 10 | 13008 2003 BIOLOGICAL & PHARMACEUTICAL BULLETIN 26(4):510-517
Usui T; Saitoh Y; Komada F
Induction of CYP3As in HepG2 cells by several drugs. - Association between induction of CYP3A4 and expression of glucocorticoid receptor | 0 | 0
|
| 13012 | 7 | 13009 2003 BIOLOGICAL & PHARMACEUTICAL BULLETIN 26(5):695-700
Satoh T; Munakata H; Fujita K; Itoh S; Itoh S; Kamataki T; Yoshizawa I
Studies on the interactions between drug and estrogen. II. On the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17 | 0 | 0
|
| 13013 | 22 | 13010 2003 BIOLOGICHESKIE MEMBRANY 20(3):265-272
Kobliakov VA
Cytochrome P-450: Functions and regulation | 0 | 0
|
| 13014 | 6 | 13011 2003 BIOORGANIC & MEDICINAL CHEMISTRY 11(13):2803-2821
Yu M; Alonso-Galicia M; Sun CW; Roman RJ; Ono N; Hirano H; Ishimoto T; Reddy YK; Katipally KR; Reddy KM; Gopal VR; Yu J; Takhi M; Falck JR
20-hydroxyeicosatetraenoic acid (20-HETE): Structural determinants for renal vasoconstriction | 0 | 0
|
| 13015 | 6 | 13012 2003 BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY 67(1):161-165
Okinaka Y; Shimada Y; Nakano-Shimada R; Ohbayashi M; Kiyokawa S; Kikuchi Y
Selective accumulation of delphinidin derivatives in tobacco using a putative flavonoid 3 ',5 '-hydroxylase cDNA from Campanula medium | 0 | 0
|
| 13016 | 12 | 13013 2003 BIOSENSORS & BIOELECTRONICS 18(2-3):237-244
Iwuoha EI; Smyth MR
Reactivities of organic phase biosensors: 6. Square-wave and differential pulse studies of genetically engineered cytochrome P450(cam) (CYP101) bioelectrodes in selected solvents | 0 | 0
|
| 13017 | 8 | 13014 2003 BRAIN 126():413-423
Taivassalo T; Jensen TD; Kennaway N; DiMauro S; Vissing J; Haller RG
The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients | 1 | 0
|
| 13018 | 16 | 13015 2003 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 55(1):77-85
Wang ZQ; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans | 0 | 0
|
| 13019 | 7 | 13016 2003 CANCER LETTERS 195(1):33-42
Sikdar N; Mahmud SA; Paul RR; Roy B
Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users | 0 | 0
|
| 13020 | 4 | 13017 2003 CANCER LETTERS 195(2):177-183
Suzuki K; Matsui H; Nakazato H; Koike H; Okugi H; Hasumi M; Ohtake N; Nakata S; Takei T; Hatori M; Ito K; Yamanaka H
Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study | 0 | 0
|
| 13021 | 2 | 13018 2003 CANCER RESEARCH 63(10):2492-2498
Grzywacz MJ; Yang JM; Hait WN
Effect of the multidrug resistance protein on the transport of the antiandrogen flutamide | 0 | 0
|
| 13022 | 3 | 13019 2003 CELL CALCIUM 33(4):283-292
Sergeeva M; Strokin M; Wang H; Ubl JJ; Reiser G
Arachidonic acid in astrocytes blocks Ca2+ oscillations by inhibiting store-operated Ca2+ entry, and causes delayed Ca2+ influx | 0 | 0
|
| 13023 | 2 | 13020 2003 CELLULAR AND MOLECULAR LIFE SCIENCES 60(4):767-775
Zaugg CE; Spaniol M; Kaufmann P; Bellahcene M; Barbosa V; Tolnay M; Buser PT; Krahenbuhl S
Myocardial function and energy metabolism in carnitine- deficient rats | 0 | 0
|
| 13024 | 19 | 13021 2003 CHEMICAL RESEARCH IN TOXICOLOGY 16(2):129-136
Lin HL; Kent UM; Zhang HM; Waskell L; Hollenberg PF
Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P4502B1 by peroxynitrite | 1 | 0
|
| 13025 | 21 | 13022 2003 CHEMICAL RESEARCH IN TOXICOLOGY 16(3):249-260
Ma Q; Lu AYH
Origins of individual variability in P4501A induction | 0 | 0
|
| 13026 | 9 | 13023 2003 CHEMICAL RESEARCH IN TOXICOLOGY 16(4):450-459
Hutzler JM; Walker GS; Wienkers LC
Inhibition of cytochrome P450 2D6: Structure-activity studies using a series of quinidine and quinine analogues | 0 | 0
|
| 13027 | 7 | 13024 2003 CIRCULATION RESEARCH 92(9):992-1000
Zhu DL; Medhora M; Campbell WB; Spitzbarth N; Baker JE; Jacobs ER
Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries | 0 | 0
|
| 13028 | 53 | 13025 2003 CLINICAL PHARMACOKINETICS 42(2):153-178
Donato MT; Castell JV
Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism - Focus on in vitro studies | 0 | 0
|
| 13029 | 1 | 13026 2003 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 6(2):147-154
Kodzius R; Rhyner C; Konthur Z; Buczek D; Lehrach H; Walter G; Crameri R
Rapid identification of allergen-encoding cDNA clones by phage display and high-density arrays | 0 | 0
|
| 13030 | 3 | 13027 2003 CONTACT DERMATITIS 48(3):137-139
Lee AY; Choi J; Chey WY
Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine | 0 | 0
|
| 13031 | 20 | 13028 2003 CRITICAL REVIEWS IN TOXICOLOGY 33(2):105-136
Weber LWD; Boll M; Stampfl A
Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model | 0 | 0
|
| 13032 | 41 | 13029 2003 CURRENT DRUG METABOLISM 4(1):73-84
Zhao X; Imig JD
Kidney CYP450 enzymes: Biological actions beyond drug metabolism | 0 | 0
|
| 13033 | 9 | 13030 2003 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 6(1):50-56
Plant NJ; Gibson GG
Evaluation of the toxicological relevance of CYP3A4 induction | 0 | 0
|
| 13034 | 20 | 13031 2003 CURRENT TOPICS IN MEDICINAL CHEMISTRY 3(11):1227-1239
Vermeulen NPE
Prediction of drug metabolism: The case of cytochrome P450 2D6 | 1 | 0
|
| 13035 | 12 | 13032 2003 DALTON TRANSACTIONS (11):2133-2140
Bell SG; Orton E; Boyd H; Stevenson JA; Riddle A; Campbell S; Wong LL
Engineering cytochrome P450cam into an alkane hydroxylase | 0 | 0
|
| 13036 | 24 | 13033 2003 DNA AND CELL BIOLOGY 22(4):243-252
Nazarov PA; Drutsa VL; Miller WL; Shkumatov VM; Luzikov VN; Novikova LA
Formation and functioning of fused cholesterol side-chain cleavage enzymes | 0 | 0
|
| 13037 | 7 | 13034 2003 DRUG METABOLISM AND DISPOSITION 31(1):1-6
Sarkar MA; Vadlamuri V; Ghosh S; Glover DD
Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle | 0 | 0
|
| 13038 | 13 | 13035 2003 DRUG METABOLISM AND DISPOSITION 31(1):60-66
Yamamoto T; Hagima N; Nakamura M; Kohno Y; Nagata K; Yamazoe Y
Differences in cytochrome P450 forms involved in the metabolism of N,N-dipropyl-2-[4-methoxy-3-(2- phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a novel sigma ligand, in human liver and intestine | 0 | 0
|
| 13039 | 19 | 13036 2003 DRUG METABOLISM AND DISPOSITION 31(3):282-288
Edwards RJ; Price RJ; Watts PS; Renwick AB; Tredger JM; Boobis AR; Lake BG
Induction of cytochrome P450 enzymes in cultured precision-cut human liver slices | 2 | 0
|
| 13040 | 14 | 13037 2003 DRUG METABOLISM AND DISPOSITION 31(4):384-391
Usmani KA; Rose RL; Hodgson E
Inhibition and activation of the human liver microsomal and human cytochrome P450 3A4 metabolism of testosterone by deployment-related chemicals | 0 | 0
|
| 13041 | 12 | 13038 2003 DRUG METABOLISM AND DISPOSITION 31(4):398-403
Jinno H; Tanaka-Kagawa T; Ohno A; Makino Y; Matsushima E; Hanioka N; Ando M
Functional characterization of cytochrome P4502B6 allelic variants | 0 | 0
|
| 13042 | 14 | 13039 2003 DRUG METABOLISM AND DISPOSITION 31(4):412-420
Liu JG; Ericksen SS; Besspiata D; Fisher CW; Szklarz GD
Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: Case of residue 382 | 0 | 0
|
| 13043 | 9 | 13040 2003 DRUG METABOLISM AND DISPOSITION 31(4):432-438
Nakamura H; Torimoto N; Ishii I; Ariyoshi N; Nakasa H; Ohmori S; Kitada M
CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids | 0 | 0
|
| 13044 | 3 | 13041 2003 DRUG METABOLISM AND DISPOSITION 31(5):523-527
Staudinger JL; Madan A; Carol KM; Parkinson A
Regulation of drug transporter gene expression by nuclear receptors | 0 | 0
|
| 13045 | 9 | 13042 2003 DRUG METABOLISM AND DISPOSITION 31(7):833-836
Kobayashi K; Urashima K; Shimada N; Chiba K
Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: Study with cDNA-expressed systems of the rat | 0 | 0
|
| 13046 | 15 | 13043 2003 DRUG METABOLISM AND DISPOSITION 31(7):846-853
Watanabe T; Morisseau C; Newman JW; Hammock BD
In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea | 0 | 0
|
| 13047 | 3 | 13044 2003 ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 54(1):1-6
Fisher T; Crane M; Callaghan A
Induction of cytochrome P-450 activity in individual Chironomus riparius Meigen larvae exposed to xenobiotics | 0 | 0
|
| 13048 | 7 | 13045 2003 ENDOCRINOLOGY 144(2):467-473
Moran FM; Vandevoort CA; Overstreet JW; Lasley BL; Conley AJ
Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Inhibition of estradiol secretion due to decreased 17 alpha- hydroxylase/17,20-lyase cytochrome P450 expression | 0 | 0
|
| 13049 | 1 | 13046 2003 ENDOCRINOLOGY 144(2):575-580
Wilson JD; Auchus RJ; Leihy MW; Guryev OL; Estabrook RW; Osborn SM; Shaw G; Renfree MB
5 alpha-androstane-3 alpha,17 beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5 alpha- pregnane-3 alpha,17 alpha-diol-20-one as a key intermediate | 0 | 0
|
| 13050 | 4 | 13047 2003 ENVIRONMENTAL AND MOLECULAR MUTAGENESIS 41(1):69-76
Sierra-Torres CH; Au WW; Arrastia CD; Cajas-Salazar N; Robazetti SC; Payne DA; Tyring SK
Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia | 0 | 0
|
| 13051 | 2 | 13048 2003 ENVIRONMENTAL HEALTH PERSPECTIVES 111(6):811-824
Waters M; Boorman G; Bushel P; Cunningham M; Irwin R; Merrick A; Olden K; Paules R; Selkirk J; Stasiewicz S; Weis B; Van Houten B; Walker N; Tennant R
Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base | 1 | 0
|
| 13052 | 11 | 13049 2003 ENVIRONMENTAL HEALTH PERSPECTIVES 111(6):855-861
Smith AG; Davies R; Dalton TP; Miller ML; Judah D; Riley J; Gant T; Nebert DW
Intrinsic hepatic phenotype associated with the Cyp1a2 gene as shown by cDNA expression microarray analysis of the knockout mouse | 1 | 0
|
| 13053 | 4 | 13050 2003 ENVIRONMENTAL SCIENCE & TECHNOLOGY 37(5):832-839
Li HX; Drouillard KG; Bennett E; Haffner GD; Letcher RJ
Plasma-associated halogenated phenolic contaminants in benthic and pelagic fish species from the Detroit River | 1 | 0
|
| 13054 | 13 | 13051 2003 ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY 22(3):636-644
Li HX; Boon JP; Lewis WE; van den Berg M; Nyman M; Letcher RJ
Hepatic microsomal cytochrome P450 enzyme activity in relation to in vitro metabolism/inhibition of polychlorinated biphenyls and testosterone in Baltic grey seal (Halichoerus grypus) | 0 | 0
|
| 13055 | 4 | 13052 2003 ENZYME AND MICROBIAL TECHNOLOGY 32(6):688-705
Fernandes P; Cruz A; Angelova B; Pinheiro HM; Cabral JMS
Microbial conversion of steroid compounds: recent developments | 0 | 0
|
| 13056 | 6 | 13053 2003 EUROPEAN JOURNAL OF BIOCHEMISTRY 270(2):222-229
Kovaleva IE; Novikova LA; Nazarov PA; Grivennikov SI; Luzikov VN
Effects of various N-terminal addressing signals on sorting and folding of mammalian CYP11A1 in yeast mitochondria | 0 | 0
|
| 13057 | 12 | 13054 2003 EUROPEAN JOURNAL OF BIOCHEMISTRY 270(7):1502-1514
Duport C; Schoepp B; Chatelain E; Spagnoli R; Dumas B; Pompon D
Critical role of the plasma membrane for expression of mammalian mitochondrial side chain cleavage activity in yeast | 0 | 0
|
| 13058 | 9 | 13055 2003 EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 33(6):493-499
Lindell M; Karlsson MO; Lennernas H; Pahlman L; Lang MA
Variable expression of CYP and Pgp genes in the human small intestine | 0 | 0
|
| 13059 | 14 | 13056 2003 EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS 28(1):41-48
Lindell M; Lang M; Lennernas H
Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver | 0 | 0
|
| 13060 | 10 | 13057 2003 EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY 54(4):273-279
Ejiri N; Katayama K; Doi K
Induction of CYP3A1 by dexamethasone and pregnenolone-16 alpha- carbonitrile in pregnant rat and fetal livers and placenta | 0 | 0
|
| 13061 | 6 | 13058 2003 FASEB JOURNAL 17(2):U514-U531
Michaelis UR; Fisslthaler B; Medhora M; Harder D; Fleming I; Busse R
Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor | 0 | 0
|
| 13062 | 4 | 13059 2003 FEBS LETTERS 536(1-3):92-96
Shen WY; Wei YD; Dauk M; Zheng ZF; Zou JT
Identification of a mitochondrial glycerol-3-phosphate dehydrogenase from Arabidopsis thaliana: evidence for a mitochondrial glycerol-3-phosphate shuttle in plants | 0 | 0
|
| 13063 | 1 | 13060 2003 FEMS YEAST RESEARCH 3(4):333-339
Lloyd D; Lemar KA; Salgado LEJ; Gould TM; Murray DB
Respiratory oscillations in yeast: mitochondrial reactive oxygen species, apoptosis and time; a hypothesis | 0 | 0
|
| 13064 | 6 | 13061 2003 GENE 305(1):133-140
Pua EC; Lee YC
Expression of a ripening-related cytochrome P450 cDNA in Cavendish banana (Musa acuminata cv. Williams) | 0 | 0
|
| 13065 | 3 | 13062 2003 IN VIVO 17(1):61-65
Peters LP; Teel RW
Effects of high sucrose diet on body and liver weight and hepatic enzyme content and activity in the rat | 0 | 0
|
| 13066 | 12 | 13063 2003 INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH 76(3):174-185
Bolt HM; Roos PH; Thier R
The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine | 0 | 0
|
| 13067 | 2 | 13064 2003 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 11(6):713-721
Nagata T; Takahashi Y; Ishii Y; Asai S; Sugahara M; Nishida Y; Murata A; Chin M; Schichino H; Koshinaga T; Fukuzawa M; Mugishima H
Profiling of genes differentially expressed between fetal liver and postnatal liver using high-density oligonucleotide DNA array | 0 | 0
|
| 13068 | 3 | 13065 2003 JOURNAL OF BACTERIOLOGY 185(12):3491-3498
Thackray PD; Moir A
SigM, an extracytoplasmic function sigma factor of Bacillus subtilis, is activated in response to cell wall antibiotics, ethanol, heat, acid, and superoxide stress | 0 | 0
|
| 13069 | 20 | 13066 2003 JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY 17(3):169-176
Arinc E; Bozcaarmutlu A
Catalyzation of cocaine N-demethylation by Cytochromes P4502B, P4503A, and P4502D in fish liver | 0 | 0
|
| 13070 | 6 | 13067 2003 JOURNAL OF BIOENERGETICS AND BIOMEMBRANES 35(2):169-179
Bello RI; Alcain FJ; Gomez-Diaz C; Consuelo G; Lopez-Lluch G; Navas P; Villalba JM
Hydrogen peroxide- and cell-density-regulated expression of NADH-cytochrome b(5) reductase in HeLa cells | 0 | 0
|
| 13071 | 7 | 13068 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(6):3580-3589
Kimura S; Kawamura M; Iyanagi T
Role of Thr(66) in porcine NADIR-cytochrome b(5) reductase in catalysis and control of the rate-limiting step in electron transfer | 1 | 0
|
| 13072 | 13 | 13071 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(23):21204-21211
Ogishima T; Kinoshita JY; Mitani F; Suematsu M; Ito A
Identification of outer mitochondrial membrane cytochrome b(5) as a modulator for androgen synthesis in Leydig cells | 0 | 0
|
| 13073 | 2 | 13072 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(25):22980-22988
Lund EG; Xie CL; Kotti T; Turley SD; Dietschy JM; Russell DW
Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover | 0 | 0
|
| 13074 | 16 | 13073 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(28):25895-25901
Gu J; Weng Y; Zhang QY; Cui HD; Behr M; Wu L; Yang WZ; Zhang L; Ding XX
Liver-specific deletion of the NADPH-cytochrome P450 reductase gene - Impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase | 0 | 0
|
| 13075 | 8 | 13074 2003 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 784(1):49-61
Friedrich G; Rose T; Rissler K
Determination of testosterone metabolites in human hepatocytes - I. Development of an on-line sample preparation liquid chromatography technique and mass spectroscopic detection of 6 beta-hydroxytestosterone | 0 | 0
|
| 13076 | 6 | 13075 2003 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 88(6):2803-2809
Quinkler M; Bumke-Vogt C; Meyer B; Bahr V; Oelkers W; Diederich S
The human kidney is a progesterone-metabolizing and androgen- producing organ | 0 | 0
|
| 13077 | 4 | 13076 2003 JOURNAL OF CLINICAL INVESTIGATION 111(1):129-139
Leu JI; Crissey MAS; Taub R
Massive hepatic apoptosis associated with TGF-beta 1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice | 1 | 0
|
| 13078 | 4 | 13077 2003 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 18(7):851-857
Tada S; Nakamoto N; Kameyama K; Tsunematsu S; Kumagai N; Saito H; Ishii H
Clinical usefulness of edaravone for acute liver injury | 0 | 0
|
| 13079 | 5 | 13078 2003 JOURNAL OF HEALTH SCIENCE 49(2):105-114
Kato J; Ikemoto A; Mizutani T
The effect of dietary fatty acids on the expression levels and activities of hepatic drug metabolizing enzymes | 0 | 0
|
| 13080 | 23 | 13079 2003 JOURNAL OF INORGANIC BIOCHEMISTRY 93(3-4):152-160
Reed JR; Hollenberg PF
Comparison of substrate metabolism by cytochromes P4502B1, 2B4, and 2B6: relationship of heme spin state, catalysis, and the effects of cytochrome b(5) | 0 | 0
|
| 13081 | 7 | 13080 2003 JOURNAL OF MOLECULAR MEDICINE-JMM 81(3):154-167
Meisel C; Gerloff T; Kirchheiner J; Mrozikiewicz PM; Niewinski P; Brockmoller J; Roots I
Implications of pharmacogenetics for individualizing drug treatment and for study design | 0 | 0
|
| 13082 | 7 | 13081 2003 JOURNAL OF PHARMACY AND PHARMACOLOGY 55(1):143-149
Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats | 0 | 0
|
| 13083 | 1 | 13082 2003 JOURNAL OF PHARMACY AND PHARMACOLOGY 55(6):847-853
Sreekanth KS; Sabu MC; Varghese L; Manesh C; Kuttan G; Kuttan R
Antioxidant activity of Smoke Shield in-vitro and in-vivo | 0 | 0
|
| 13084 | 8 | 13083 2003 JOURNAL OF PHYCOLOGY 39(3):555-560
Yang S; Wu RSS; Mok HOL; Zhang ZP; Kong RYC
Identification of a novel cytochrome P450 cDNA, CYP97E1, from the marine diatom Skeletonema costatum Bacillariophyceae | 0 | 0
|
| 13085 | 13 | 13084 2003 JOURNAL OF PSYCHIATRY & NEUROSCIENCE 28(2):99-112
Prior TI; Baker GB
Interactions between the cytochrome P450 system and the second- generation antipsychotics | 0 | 0
|
| 13086 | 7 | 13086 2003 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 125(27):8209-8217
Hollmann F; Lin PC; Witholt B; Schmid A
Stereospecific biocatalytic epoxidation: The first example of direct regeneration of a FAD-dependent monooxygenase for catalysis | 0 | 0
|
| 13087 | 3 | 13087 2003 JOURNAL OF VECTOR ECOLOGY 28(1):108-116
Chareonviriyaphap T; Rongnoparut P; Chantarumporn P; Bangs MJ
Biochemical detection of pyrethroid resistance mechanisms in Anopheles minimus in Thailand | 0 | 0
|
| 13088 | 16 | 13088 2003 KIDNEY INTERNATIONAL 63(5):1687-1696
Liu H; Baliga R
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis | 0 | 0
|
| 13089 | 12 | 13089 2003 LANCET NEUROLOGY 2(7):404-409
Vecht CJ; Wagner GL; Wilms EB
Interactions between antiepileptic and chemotherapeutic drugs | 0 | 0
|
| 13090 | 2 | 13090 2003 LIFE SCIENCES 72(17):1953-1962
Xu BQ; Ishii M; Ding LR; Fischer NE; Inaba T
Interaction of serum proteins with CYP isoforms in human liver microsomes: inhibitory effects of human and bovine albumin, alpha-globulins, alpha-1-acid glycoproteins and gamma-globulins on CYP2C19 and CYP2D6 | 0 | 0
|
| 13091 | 10 | 13091 2003 LIFE SCIENCES 73(2):141-149
Elizondo G; Medina-Diaz IM
Induction of CYP3A4 by 1 alpha,25-dyhydroxyvitamin D-3 in HepG2 cells | 0 | 0
|
| 13092 | 5 | 13092 2003 MACROMOLECULES 36(4):1021-1027
Rosen GM; Porasuphatana S; Tsai P; Ambulos NP; Galtsev VE; Ichikawa K; Halpern HJ
Dendrimeric-containing nitronyl nitroxides as spin traps for nitric oxide: Ssynthesis, kinetic, and stability studies | 0 | 0
|
| 13093 | 3 | 13093 2003 MOLECULAR CARCINOGENESIS 37(1):39-50
Liu JD; Wang YJ; Chen CH; Yu CF; Chen LC; Lin JK; Liang YC; Lin SY; Ho YS
Molecular mechanisms of G(0)/G(1) cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells | 0 | 0
|
| 13094 | 6 | 13094 2003 MOLECULAR PHARMACOLOGY 63(3):722-731
Gu S; Ripp SL; Prough RA; Geoghegan TE
Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11 beta-hydroxysteroid dehydrogenase type 1: A cDNA array analysis | 0 | 0
|
| 13095 | 11 | 13095 2003 MOLECULAR PHARMACOLOGY 64(1):113-122
Ripp SL; Falkner KC; Pendleton ML; Tamasi V; Prough RA
Regulation of CYP2C11 by dehydroepiandrosterone and peroxisome proliferators: Identification of the negative regulatory region of the gene | 0 | 0
|
| 13096 | 4 | 13096 2003 MUTAGENESIS 18(1):25-36
Buschini A; Poli P; Rossi C
Saccharomyces cerevisiae as an eukaryotic cell model to assess cytotoxicity and genotoxicity of three anticancer anthraquinones | 0 | 0
|
| 13097 | 12 | 13097 2003 MUTAGENESIS 18(1):95-100
Cancino-Badias L; Reyes RE; Nosti R; Perez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
Modulation of rat liver citochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods | 1 | 0
|
| 13098 | 12 | 13098 2003 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 523():173-182
Guengerich FP; Chun YJ; Kim D; Gillam EMJ; Shimada T
Cytochrome P4501B1: a target for inhibition in anticarcinogenesis strategies | 1 | 0
|
| 13099 | 8 | 13099 2003 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 527(1-2):67-80
Sapone A; Affatato A; Canistro D; Broccoli M; Trespidi S; Pozzetti L; Biagi GL; Cantelli-Forti G; Paolini M
Induction and suppression of cytochrome P450 isoenzymes and generation of oxygen radicals by procymidone in liver, kidney and lung of CD1 mice | 0 | 0
|
| 13100 | 9 | 13100 2003 NEUROSCIENCE 117(3):521-529
Hagemeyer CE; Rosenbrock H; Ditter M; Knoth R; Volk B
Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain | 0 | 0
|
| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 13101 | 7 | 13101 2003 NUCLEIC ACIDS RESEARCH 31(7):1944-1954
Mannhaupt G; Montrone C; Haase D; Mewes HW; Aign V; Hoheisel JD; Fartmann B; Nyakatura G; Kempken F; Maier J; Schulte U
What's in the genome of a filamentous fungus? Analysis of the Neurospora genome sequence | 1 | 0
|
| 13102 | 6 | 13102 2003 PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY 75(1-2):19-26
Shen B; Dong HQ; Tian HS; Ma L; Li XL; Wu GL; Zhu CL
Cytochrome P450 genes expressed in the deltamethrin-susceptible and -resistant strains of Culex pipiens pallens | 0 | 0
|
| 13103 | 8 | 13103 2003 PHARMACOLOGICAL RESEARCH 48(1):1-9
Ferrari A; Sternieri E; Ferraris E; Bertolini A
Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis | 0 | 0
|
| 13104 | 69 | 13104 2003 PHARMACOLOGY & THERAPEUTICS 97(2):139-152
Schenkman JB; Jansson I
The many roles of cytochrome b(5) | 0 | 0
|
| 13105 | 41 | 13105 2003 PHARMACOLOGY & THERAPEUTICS 98(2):221-233
Backes WL; Kelley RW
Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes | 0 | 0
|
| 13106 | 7 | 13106 2003 PLANT PHYSIOLOGY 131(1):287-297
Shimada Y; Goda H; Nakamura A; Takatsuto S; Fujioka S; Yoshida S
Organ-specific expression of brassinosteroid-biosynthetic genes and distribution of endogenous brassinosteroids in Arabidopsis | 0 | 0
|
| 13107 | 9 | 13107 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(4):1558-1563
Newman JW; Morisseau C; Harris TR; Hammock BD
The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity | 0 | 0
|
| 13108 | 2 | 13108 2003 PROTEIN EXPRESSION AND PURIFICATION 28(1):131-139
Kato Y; Asano Y
High-level expression of a novel FMN-dependent heme-containing lyase, phenylacetaldoxime dehydratase of Bacillus sp strain OxB-1, in heterologous hosts | 0 | 0
|
| 13109 | 10 | 13109 2003 PROTEIN EXPRESSION AND PURIFICATION 29(1):1-7
Hayashi S; Omata Y; Sakamoto H; Hara T; Noguchi M
Purification and characterization of a soluble form of rat liver NADPH-cytochrome P-450 reductase highly expressed in Escherichia coli | 0 | 0
|
| 13110 | 8 | 13110 2003 PROTEIN EXPRESSION AND PURIFICATION 30(1):43-54
Davis CA; Barber MJ
Heterologous expression of enzymopenic methemoglobinemia variants using a novel NADH : cytochrome c reductase fusion protein | 0 | 0
|
| 13111 | 5 | 13111 2003 RAPID COMMUNICATIONS IN MASS SPECTROMETRY 17(4):307-313
Yu C; Shin YG; Kosmeder JW; Pezzuto JM; van Breemen RB
Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate | 0 | 0
|
| 13112 | 2 | 13112 2003 STEROIDS 68(3):235-243
de Gooyer ME; Oppers-Tiemissen HM; Leysen D; Verheul HAM; Kloosterboer HJ
Tibolone is not converted by human aromatase to 7 alpha-methyl- 17 alpha-ethynylestradiol (7 alpha-MEE): Analyses with sensitive bioassays for estrogens and androgens and with LC- MSMS | 0 | 0
|
| 13113 | 2 | 13113 2003 TETRAHEDRON 59(2):135-139
Spiteller D; Boland W
N-(15,16-Dihydroxylinoleoyl)-glutamine and N-(15,16- epoxylinoleoyl)-glutamine isolated from oral secretions of lepidopteran larvae | 0 | 0
|
| 13114 | 3 | 13114 2003 TOXICOLOGICAL SCIENCES 73(2):386-402
Boess F; Kamber M; Romer S; Gasser R; Muller D; Albertini S; Suter L
Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: Possible implications for toxicogenomics use of in vitro systems | 0 | 0
|
| 13115 | 20 | 13115 2003 TOXICOLOGY 187(1):49-65
Sivapathasundaram S; Magnisali P; Coldham NG; Howells LC; Sauer MJ; Ioannides C
Cytochrome P450 expression and testosterone metabolism in the liver of deer | 0 | 0
|
| 13116 | 13 | 13116 2003 TRENDS IN BIOTECHNOLOGY 21(4):170-177
van Beilen JB; Duetz WA; Schmid A; Witholt B
Practical issues in the application of oxygenases | 0 | 0
|
| 13117 | 1 | 13117 2003 TRENDS IN ECOLOGY & EVOLUTION 18(1):2-4
Bromham L; Eyre-Walker A; Smith NH; Smith JM
Mitochondrial Steve: paternal inheritance of mitochondria in humans | 0 | 0
|
| 13118 | 16 | 13118 2003 WORLD JOURNAL OF GASTROENTEROLOGY 9(2):359-363
Yang LQ; Li SJ; Cao YF; Man XB; Yu WF; Wang HY; Wu MC
Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases | 0 | 0
|
| 13119 | 15 | 13119 2003 XENOBIOTICA 33(5):511-527
Meredith C; Scott MP; Renwick AB; Price RJ; Lake BG
Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices | 0 | 0
|
| 13120 | 9 | 13120 2003 XENOBIOTICA 33(6):575-586
Hanioka N; Tanaka-Kagawa T; Miyata Y; Matsushima E; Makino Y; Ohno A; Yoda R; Jinno H; Ando M
Functional characterization of three human cytochrome P450 2E1 variants with amino acid substitutions | 0 | 0
|
| 13121 | 8 | 13121 2003 XENOBIOTICA 33(6):603-613
Ueng YF; Kuo YH; Peng HC; Chen TL; Jan WC; Guengerich FP; Lin YL
Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome P4501A2 | 0 | 0
|